{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:27:29Z","timestamp":1788956849064,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["1SD2524N"],"award-info":[{"award-number":["1SD2524N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.vaccine.2025.126865","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T04:54:56Z","timestamp":1740027296000},"page":"126865","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["SARS-CoV-2 seroreversion and all-cause mortality in nursing home residents and staff post-primary course vaccination in Belgium between February and December 2021"],"prefix":"10.1016","volume":"51","author":[{"given":"Eline","family":"Meyers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liselore","family":"De Rop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Deschepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els","family":"Duysburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine","family":"De Burghgraeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Van Ngoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Digregorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Coen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nele","family":"De Clercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Wallaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La\u00ebtitia","family":"Buret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Coenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"De Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Scholtes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Y.","family":"Verbakel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet","family":"Cools","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Heytens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2025.126865_bb0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13690-022-00794-6","article-title":"COVID-19 cases, hospitalizations and deaths in Belgian nursing homes: results of a surveillance conducted between April and December 2020","volume":"80","author":"Vandael","year":"2022","journal-title":"Arch Public Health"},{"key":"10.1016\/j.vaccine.2025.126865_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S095026882200036X","article-title":"Pre-vaccination SARS-CoV-2 seroprevalence among staff and residents of nursing homes in Flanders (Belgium) in fall 2020","volume":"150","author":"Janssens","year":"2022","journal-title":"Epidemiol Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126865_bb0020","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/S2666-7568(20)30011-8","article-title":"Tackling immunosenescence to improve COVID-19 outcomes and vaccine response in older adults","volume":"1","author":"Cox","year":"2020","journal-title":"The Lancet Healthy Longevity"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126865_bb0025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/(SICI)1096-9071(199805)55:1<82::AID-JMV13>3.0.CO;2-1","article-title":"Altered antibody response to influenza H1N1 vaccine in healthy elderly people as determined by HI, ELISA, and neutralization assay","volume":"55","author":"Remarque","year":"1998","journal-title":"J Med Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126865_bb0030","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.vaccine.2005.08.105","article-title":"Antibody response to influenza vaccination in the elderly: a quantitative review","volume":"24","author":"Goodwin","year":"2006","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126865_bb0035","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jamda.2021.06.023","article-title":"Factors associated with COVID-19 hospitalizations and deaths in French nursing homes","volume":"22","author":"Couderc","year":"2021","journal-title":"J Am Med Dir Assoc"},{"issue":"17","key":"10.1016\/j.vaccine.2025.126865_bb0040","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/j.vaccine.2021.03.066","article-title":"Are vaccines against COVID-19 tailored to the most vulnerable people?","volume":"39","author":"Antonelli Incalzi","year":"2021","journal-title":"Vaccine"},{"issue":"27","key":"10.1016\/j.vaccine.2025.126865_bb0045","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126865_bb0050","doi-asserted-by":"crossref","first-page":"2149732","DOI":"10.1080\/13814788.2022.2149732","article-title":"Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign","volume":"29","author":"Meyers","year":"2023","journal-title":"Eur J Gen Pract"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126865_bb0055","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.3390\/v14112361","article-title":"Declining prevalence of SARS-CoV-2 antibodies among vaccinated nursing home residents and staff six months after the primary BNT162b2 vaccination campaign in Belgium: a prospective cohort study","volume":"14","author":"Meyers","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2025.126865_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2021.104897","article-title":"Performance of five rapid serological tests in mild-diseased subjects using finger prick blood for exposure assessment to SARS-CoV-2","volume":"142","author":"Triest","year":"2021","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2025.126865_bb0075","series-title":"Katz index of Independence in activities of daily living (ADL). Best practices in nursing care to older adults: The Hartford institute for geriatric nursing","author":"Wallace","year":"1998"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126865_bb0080","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12877-022-02884-0","article-title":"Sero-survey on long-term care facility residents reveals increased risk of sub-optimal antibody response to BNT162b2: implications for breakthrough prevention","volume":"22","author":"Caimi","year":"2022","journal-title":"BMC Geriatr"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126865_bb0085","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/vaccines10020260","article-title":"Humoral and cellular responses to COVID-19 vaccination indicate the need for post-vaccination testing in frail population","volume":"10","author":"Witkowski","year":"2022","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126865_bb0090","doi-asserted-by":"crossref","first-page":"e695","DOI":"10.1093\/cid\/ciab998","article-title":"Poor antibody response to BioNTech\/Pfizer coronavirus disease 2019 vaccination in severe acute respiratory syndrome coronavirus 2\u2013naive residents of nursing homes","volume":"75","author":"Pannus","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126865_bb0095","first-page":"1690","article-title":"Dynamics of the cellular and humoral immune response after BNT162b2 messenger ribonucleic acid coronavirus disease 2019 (COVID-19) vaccination in COVID-19-naive nursing home residents","volume":"224","author":"Van Praet","year":"2021","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126865_bb0100","doi-asserted-by":"crossref","first-page":"e884","DOI":"10.1093\/cid\/ciab963","article-title":"Significant reduction in vaccine-induced antibody levels and neutralization activity among healthcare workers and nursing home residents 6 months following coronavirus disease 2019 BNT162b2 mRNA vaccination","volume":"75","author":"Canaday","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126865_bb0105","doi-asserted-by":"crossref","first-page":"13749","DOI":"10.1038\/s41598-022-18041-x","article-title":"Antibody response after first and second BNT162b2 vaccination to predict the need for subsequent injections in nursing home residents","volume":"12","author":"Tuaillon","year":"2022","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126865_bb0110","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.1016\/S2666-7568(22)00118-0","article-title":"Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study","volume":"3","author":"Tut","year":"2022","journal-title":"The Lancet Healthy Longevity"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126865_bb0115","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.jamda.2021.06.006","article-title":"Antibody responses after mRNA-based COVID-19 vaccination in residential older adults: implications for reopening","volume":"22","author":"Nace","year":"2021","journal-title":"J Am Med Dir Assoc"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126865_bb0120","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s40266-022-00959-6","article-title":"Safety, effectiveness, and immunogenicity 6 months after BNT162B2 mRNA vaccine in frail nursing home residents","volume":"39","author":"Montejano-Herv\u00e1s","year":"2022","journal-title":"Drugs Aging"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126865_bb0125","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jamda.2021.12.001","article-title":"Previous SARS-CoV-2 infection, age, and frailty are associated with 6-month vaccine-induced anti-spike antibody titer in nursing home residents","volume":"23","author":"Dyer","year":"2022","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.vaccine.2025.126865_bb0130","first-page":"13","article-title":"SARS-CoV-2 antibody response after mRNA vaccination in healthcare workers with and without previous COVID-19, a follow-up study from the University Hospital in Krakow, Poland","author":"Owsianka","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126865_bb0135","doi-asserted-by":"crossref","first-page":"8707","DOI":"10.1038\/s41598-022-12809-x","article-title":"Antibody response and seroprevalence in healthcare workers after the BNT162b2 vaccination in a University Hospital at Tokyo","volume":"12","author":"Igawa","year":"2022","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126865_bb0140","first-page":"1366","article-title":"Frailty and COVID-19 mRNA vaccine antibody response in the COVID-19 community research partnership","volume":"77","author":"Semelka","year":"2022","journal-title":"The Journals of Gerontology: Series A"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126865_bb0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cger.2010.08.002","article-title":"Inflammation and immune system alterations in frailty","volume":"27","author":"Yao","year":"2011","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.vaccine.2025.126865_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2008.05.355","article-title":"Frailty and immune response to pneumococcal vaccines among the elderly hospitalised patients","volume":"12","author":"MacIntyre","year":"2008","journal-title":"Int J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126865_bb0155","first-page":"466","article-title":"Frailty, inflammation, and immunity","volume":"2","author":"Li","year":"2011","journal-title":"Aging Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126865_bb0160","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.1002\/jmv.27098","article-title":"Quantitation of antibodies against SARS-CoV-2 spike protein after two doses of CoronaVac in healthcare workers","volume":"93","author":"Bayram","year":"2021","journal-title":"J Med Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126865_bb0165","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1002\/jmv.27604","article-title":"Dynamics of antibody response to CoronaVac vaccine","volume":"94","author":"Fonseca","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2025.126865_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.802858","article-title":"Characterization of SARS-CoV-2-specific humoral and cellular immune responses induced by inactivated COVID-19 vaccines in a real-world setting","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126865_bb0175","article-title":"Multimorbidity and serological response to SARS-CoV-2 nine months after 1st vaccine dose: European cohort of healthcare workers-orchestra project","volume":"11","author":"Viol\u00e1n","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126865_bb0180","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12985-023-02056-5","article-title":"Impact of comorbidities on the serological response to COVID-19 vaccination in a Taiwanese cohort","volume":"20","author":"Huang","year":"2023","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2025.126865_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101576","article-title":"Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: a community-based, prospective, longitudinal cohort study","volume":"51","author":"Bruel","year":"2022","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.vaccine.2025.126865_bb0190","doi-asserted-by":"crossref","first-page":"104066","DOI":"10.1016\/j.ebiom.2022.104066","article-title":"COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents","volume":"80","author":"Canaday","year":"2022","journal-title":"eBioMedicine"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126865_bb0195","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s40520-021-01855-6","article-title":"Mortality attributable to COVID-19 in nursing home residents: a retrospective study","volume":"33","author":"Veronese","year":"2021","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.vaccine.2025.126865_bb0200","doi-asserted-by":"crossref","DOI":"10.1017\/S1463423622000640","article-title":"Association between vaccination and preventive routines on COVID-19-related mortality in nursing home facilities: a population-based systematic retrospective chart review","volume":"23","author":"Nilsson","year":"2022","journal-title":"Prim Health Care Res Dev"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126865_bb0205","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1159\/000523701","article-title":"COVID-19 outbreaks in nursing homes despite full vaccination with BNT162b2 of a majority of residents","volume":"68","author":"Lafuente-Lafuente","year":"2022","journal-title":"Gerontology"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126865_bb0210","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jamda.2021.02.019","article-title":"Increase in frailty in nursing home survivors of coronavirus disease 2019: comparison with noninfected residents","volume":"22","author":"Greco","year":"2021","journal-title":"J Am Med Dir Assoc"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126865_bb0215","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jamda.2022.06.005","article-title":"Short- and long-term mortality and mortality risk factors among nursing home patients after COVID-19 infection","volume":"23","author":"Booij","year":"2022","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126865_bb0220","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/infdis\/jiab515","article-title":"Risk factors for COVID-19 deaths among elderly nursing home Medicare beneficiaries in the Prevaccine period","volume":"225","author":"Lu","year":"2022","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126865_bb0225","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3233\/JAD-210319","article-title":"Dementia and Parkinson\u2019s disease: risk factors for 30-day mortality in nursing home residents with COVID-19","volume":"84","author":"Rutten","year":"2021","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126865_bb0230","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/jamainternmed.2020.7968","article-title":"Risk factors associated with all-cause 30-day mortality in nursing home residents with COVID-19","volume":"181","author":"Panagiotou","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126865_bb0235","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/ageing\/afz136","article-title":"Morbidity and mortality among older people admitted to nursing home","volume":"49","author":"Reilev","year":"2019","journal-title":"Age Ageing"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126865_bb0240","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/ageing\/afaa184","article-title":"Association of frailty with mortality in older inpatients with Covid-19: a cohort study","volume":"49","author":"Aw","year":"2020","journal-title":"Age Ageing"},{"key":"10.1016\/j.vaccine.2025.126865_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2020.104324","article-title":"Clinical frailty scale and mortality in COVID-19: a systematic review and dose-response meta-analysis","volume":"93","author":"Pranata","year":"2021","journal-title":"Arch Gerontol Geriatr"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126865_bb0250","article-title":"Risk factors for mortality in nursing home residents: an observational study","volume":"5","author":"Garcia-Gollarte","year":"2020","journal-title":"Geriatrics (Basel)"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126865_bb0255","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-069997","article-title":"Validation of a rapid SARS-CoV-2 antibody test in general practice","volume":"13","author":"Domen","year":"2023","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126865_bb0260","first-page":"328","article-title":"A comparative overview of SARS-CoV-2 and its variants of concern","volume":"30","author":"Ahmad","year":"2022","journal-title":"Infez Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25001628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25001628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T17:41:18Z","timestamp":1762278078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25001628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":49,"alternative-id":["S0264410X25001628"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126865","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 seroreversion and all-cause mortality in nursing home residents and staff post-primary course vaccination in Belgium between February and December 2021","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126865","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126865"}}